2,931 karma · joined February 28, 2009
The most parsimonious explanation is either our models or methods (or both) are garbage. Something’s missing. The failure rate is insane, and writing it off as ambition or “biology is hard” rather than digging in does us no favors.
At least in the US tax-exempt status carries obligations.
Apple alleges not only individual malfeasance, but also recruitment tactics like “show-and-tell” aimed at recruiting those willing to bring company secrets (and discriminating against those who would not).
This is enough to constitute a low-trust culture that self-perpetuates.
Surely given the size of China there are plenty of honorable people. And surely in the US there are many dishonorable people, as you’ve pointed out.
[1]: https://www.documentcloud.org/documents/21211671-1997-revisi...
Regulators don’t make cures. There’s room to improve on that side of the system.
Especially as emerging approaches seem to be trending more systems-thinking-oriented, eg “this will strengthen your immune system to fight lots of diseases.”
Churn is built in to the specialty. Read into that what you will.
[1]: https://www.apa.org/practice/guidelines/criteria?item=5
To be clear, the FDA regulates marketing claims. “Is the label accurate?”
Major decisions about life and death are between the doctor and the patient, not the FDA.
It sounds like you’re taking an expansive view of this government agency’s mandate. People will push back on this at the ballot box, even if they can’t put it to words themselves.
That is not a general principle. Consider the following: it is now illegal to say the word “election” because it would harm the President.
I disagree wrt reasonableness. It’s just too big a leap. There are a lot of crimes, and not many land you on death row.
Interesting, hadn’t heard. I can’t wait to see where this goes.
Working with regulators is a terrible experience. I hope they can fix this as well.